Marker Therapeutics MRKR
NASDAQ MRKR
$1.05 -0.02 (-1.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Interest Expenses (2010 - 2014)

Updated

Marker Therapeutics' Interest Expenses was $10,925 in FY2015.

Analysis

Marker Therapeutics (MRKR) Interest Expenses (2010 - 2014) Analysis & Trends

From FY2010 onward, Marker Therapeutics has reported Interest Expenses for 4 years.

  • Interest Expenses shows a five-year compound annual growth rate of -61.2% (FY2010 to FY2015).
  • The FY2015 figure marks the highest annual Interest Expenses since FY2012.
  • Per Business Quant data, Interest Expenses in earlier years was $745,074 in FY2012 (+9.7%) and $679,332 in FY2011 (-45.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Marker Therapeutics 17.87 Mn -42.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 15,425.00
Mar 31, 2014 35,269.00
Mar 31, 2013 334,888.00
Jun 30, 2012 100,246.00
Mar 31, 2012 96,726.00
Dec 31, 2011 120,755.00
Sep 30, 2011 103,740.00
Jun 30, 2011 98,127.00
Mar 31, 2011 356,710.00
Dec 31, 2010 446,660.00
Sep 30, 2010 458,565.00
Jun 30, 2010 170,257.00
API Access

Marker Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=MRKR&period=max&api_key=YOUR_API_KEY